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Abstract 
Background: In intensive care unit (ICU) patients, diaphragmatic dysfunction (DD) can occur on admission or during 
the subsequent stay. The respective incidence of these two phenomena has not been previously studied in humans. 
The study was designed to describe temporal trends in diaphragm function in mechanically ventilated (MV) patients.
Methods: Ancillary study of a prospective, 6-month, observational cohort study conducted in two ICUs. MV patients 
were studied within 24 h following intubation (day-1) and every 48–72 h thereafter. Diaphragm function was assessed 
by twitch tracheal pressure (Ptr,stim) in response to bilateral anterior magnetic phrenic nerve stimulation. Diaphragm 
dysfunction was defined as Ptr,stim < 11 cmH2O. Patients who received MV for at least 5 days were retained, and the 
first and the last measures were analysed.
Results: Forty-three patients were included. Overall, 79 % of patients developed DD at some point during their 
ICU stay: 23 (53 %) patients presented DD on initiation of mechanical ventilation, 14 (33 %) of whom had persistent 
DD, while diaphragm function improved in 9 (21 %). Among the remaining 20 (47 %) patients who did not present 
DD on initiation of MV, 11 (26 %) developed DD during the ICU stay, while 9 (21 %) did not. Mortality was higher in 
patients with DD either on initiation of mechanical ventilation or during the subsequent ICU stay than in those who 
never developed DD (35 vs. 0 %, p = 0.04). Duration of MV was higher in patients with DD on initiation of MV that 
subsequently persisted than in patients who never exhibited diaphragm dysfunction (18 vs. 5 days, p = 0.04). Factors 
associated with a change in Ptr,stim were: age [linear coefficient regression (Coeff.) −0.097, standard error (SD) 0.047, 
p = 0.046], PaO2/FiO2 ratio (Coeff. 0.014, SD 0.006, p = 0.0211) and the proportion of the time under MV with sedation 
(per 10 %, Coeff. −5.359, SD 2.451, p = 0.035).
Conclusions: DD is observed in a large majority of MV patients ≥5 days at some point of their ICU stay. Various pat-
terns of DD are observed, including DD on initiation of mechanical ventilation and ICU-acquired DD.
Trial registration clinicaltrials.gov Identifier # NCT00786526
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Background
 Diaphragm function is a major determinant of weaning 
from mechanical ventilation in intensive care unit (ICU) 
patients and influences the duration of mechanical venti-
lation [1]. It has become a major concern in ICU patients 
and the subject of an increasing number of reports [2].
To date, two major patterns of diaphragm dysfunc-
tion have been described in ICU patients. First, the 
diaphragm, like all organs, can be involved in the shock-
related generalized organ failure observed in many 
patients on admission to the ICU [3]. This occurs in 64 % 
of patients, is determined by sepsis and the severity of 
the disease and is associated with higher mortality [3]. 
Second, diaphragm dysfunction in critically ill patients 
can occur during the ICU stay in patients without prior 
diaphragm dysfunction [4, 5]. It can be a consequence of 
ICU-acquired neuromuscular disorders [6]. It can also be 
a negative consequence of mechanical ventilation per se, 
which is associated with a time-dependent decrease of 
diaphragm strength called ventilator-induced diaphragm 
dysfunction (VIDD) [7].
The relative distribution of these patterns has not yet 
been described, since previous reports have focused on 
only one of these two patterns [3, 5].
The present study addresses this issue by means of 
longitudinal measurement of tracheal twitch pressure 
(Ptr,sim) following magnetic stimulation of the phrenic 
nerve in intubated and mechanically ventilated patients. 
Ptr,stim was first measured during the first 24 h follow-
ing intubation and initiation of mechanical ventilation 
and then every 48–72 h in patients receiving mechanical 
ventilation for more than 5 days. The study was designed 
to describe temporal trends in diaphragm function, iden-
tify putative clinical factors associated with diaphragm 
dysfunction and describe the subsequent impact of these 
changes on the patient’s outcome.
Patients and methods
The study was conducted over a 6-month period (1 
December 2008 to 1 July 2009) in two intensive care 
units: A 10-bed medical intensive care unit (ICU) 
(Groupe Hospitalier Pitié-Salpêtrière, Paris) and a 16-bed 
medical and surgical ICU (Hôpital Saint-Eloi, Montpel-
lier). The study was approved by the “Comité de Protec-
tion des Personnes Sud-Méditerrannée II”, Montpellier, 
France. All patients or their relatives provided written 
informed consent to participate. Data from this cohort 
have been presented in previously published studies [3, 
5]. This study was registered in the US National Insti-
tutes of Health clinical trials registry (clinicaltrials.gov 
NCT00786526).
Patients
Patients were eligible for inclusion in the study within the 
24  h following intubation and initiation of mechanical 
ventilation. Exclusion criteria were an expected duration 
of mechanical ventilation less than 48  h, contraindica-
tions to magnetic stimulation of the phrenic nerves 
(cardiac pacemaker or implanted defibrillator, cervical 
implants), use of neuromuscular blocking agents within 
the 24  h preceding the first diaphragm function assess-
ment (with the exception of succinylcholine used during 
rapid-sequence induction of anaesthesia for intubation), 
pre-existing neuromuscular disorders, cervical spine 
injury, factors possibly interfering with tracheal pressure 
measurements in response to phrenic stimulation (mul-
tiple functioning chest drains, severe chronic obstruc-
tive pulmonary disease). Finally, age less than 18  years, 
known pregnancy, and a decision to withhold life-sus-
taining treatment also constituted exclusion criteria.
Diaphragm assessment
Diaphragm performance was assessed in terms of 
changes in endotracheal tube pressure induced by bilat-
eral phrenic nerve stimulation during airway occlusion 
(Ptr,stim). The first Ptr,stim measurement was performed 
within 24 h of intubation, and, whenever possible, these 
measurements were repeated every 48–72 h until extuba-
tion or death.
Phrenic nerve stimulation was performed by bilateral 
anterior magnetic stimulation [8]. Briefly, two figure-of-
eight coils connected to a pair of Magstim® 200 stimula-
tors (The Magstim Company, Dyfed, UK) were positioned 
immediately posterior to the sternocleidomastoid mus-
cles at the level of the cricoid cartilage. Stimulations were 
delivered at the maximum intensity allowed by the stimu-
lator. The patients were studied in a standardized semi-
recumbent position as follows: end-expiratory pressure 
was set to zero, and the patient was allowed to exhale 
during an end-expiratory pause until expiratory airflow 
reached zero (relaxed equilibrium volume of the respira-
tory system). The endotracheal tube was then occluded, 
and bilateral anterolateral magnetic stimulation was 
performed. The absence of active respiratory efforts in 
response to stimulation was determined by checking the 
stability of the airway pressure signal. Measurements 
were repeated at least three times and were performed by 
the two same operators in each centre. Stimulations were 
always performed by the same two operators in each cen-
tre. Ptr,stim was defined as the amplitude of the negative 
pressure wave following stimulation, determined from 
baseline to peak. It was measured at the proximal end of 
the endotracheal tube, using a linear differential pressure 
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transducer (MP45 ±  100 cmH2O, Validyne, Northridge, 
CA, USA). The pressure signal was sampled and digitized 
at 128  Hz (MP30, Biopac Systems, Santa Barbara, CA, 
USA or Powerlab, AD Instruments, Bella Vista, Australia) 
for subsequent data analysis.
Clinical data collection
Demographic data, severity scores, organ dysfunction-
related variables, presence of sepsis [9] and blood gas 
data were recorded prospectively on ICU admission, at 
day 1. Administration of mechanical ventilation, sedation 
and catecholamines was recorded each day. The dura-
tions of mechanical ventilation, ICU stay and hospital 
stay were also recorded, as were decisions to perform tra-
cheotomy, ICU mortality and hospital mortality.
Statistical analysis
Because the present study was designed to investi-
gate temporal trends in diaphragm function during 
mechanical ventilation, only patients who received 
mechanical ventilation for at least 5  days were retained 
and the first and the last measures were considered in 
the analysis. Diaphragm dysfunction was defined as 
Ptr,stim < 11 cmH2O [3, 10, 11].
Patients were further qualified according to four pat-
terns according to the presence or absence of diaphragm 
dysfunction on initiation of MV and during the subse-
quent ICU stay:
(1)   “Persistent Dysfunction” defined patients with 
diaphragm dysfunction on initiation of MV 
(Ptr,stim  <  11  cmH2O) and persistent dia-
phragm dysfunction during the ICU stay (Ptr,stim 
remained < 11 cmH2O),
(2)   “Improving Dysfunction” defined patients with 
diaphragm dysfunction on initiation of MV 
(Ptr,stim  <  11  cmH2O), but in whom diaphragm 
function improved during the ICU stay (Ptr,stim 
increased to ≥ 11 cmH2O),
(3)   “Acquired Dysfunction” defined patients with-
out diaphragm dysfunction on initiation of 
MV (Ptr,stim  ≥  11  cmH2O), but who acquired 
diaphragm dysfunction (Ptr,stim decreased 
to < 11 cmH2O) during the ICU stay,
(4)   “No Dysfunction” defined patients without 
diaphragm dysfunction on initiation of MV 
(Ptr,stim  ≥  11  cmH2O) and in whom diaphragm 
function remained normal throughout the ICU stay 
(Ptr,stim remained ≥ 11 cmH2O).
Factors associated with these patterns of diaphragm 
function as well as factors associated with changes in 
diaphragm function were assessed. These factors were: 
age, gender, body mass index, SAPS II, type of admission, 
SOFA, sepsis, blood gases, blood lactate, sedation, amines 
and controlled mechanical ventilation (as opposed to 
partial modes). The relationship between potential factor 
of diaphragm dysfunction and the four predefined pat-
terns of diaphragm dysfunction was evaluated in a uni-
variate model (one-way ANOVA or Kruskal–Wallis test 
for continuous variables depending on distribution; Chi-
square test or Fisher’s exact test for categorical variables 
depending on size). In addition, in order to analyse the 
level of Ptr,stim as a continuous endpoint over time, lin-
ear mixed effects models were performed.
The impact of time trend of Ptr,stim on ICU and hospi-
tal mortality, tracheostomy rate, duration of mechanical 
ventilation and length of stay was also assessed in a uni-
variate model.
For all final comparisons, a p value ≤0.05 was consid-
ered statistically significant without any correction for 
multiple comparisons. Statistical analysis was performed 
with R software (version R.2.13.2). The median and inter-
quartile range (IQR) are reported for continuous vari-




Eighty-five patients were enrolled during the study 
period [3]: Forty-three of them were both mechanically 
ventilated ≥5  days and had ≥3 Ptr,stim measurements. 
The mean age was 61 (54–77) years, and the mean SAPS 
2 score was 53 (44–65).
Prevalence and factors associated with changes 
in diaphragm function in the ICU
Figure 1 displays the distribution of patients according to 
the four predefined patterns. Twenty-three patients pre-
sented diaphragm dysfunction on admission, 14 (33 %) of 
whom had persistent diaphragm dysfunction (“Persistent 
Dysfunction” pattern) and 9 (21 %) had improvement of 
diaphragm function (“Improving Dysfunction” pattern). 
Among the remaining 20 patients who did not present 
diaphragm dysfunction on admission, 11 (26  %) subse-
quently developed diaphragm dysfunction (“Acquired 
Dysfunction” pattern) and 9 (21  %) did not present any 
diaphragm dysfunction during the ICU stay (“No Dys-
function” pattern). Overall, 34 (79 %) patients developed 
DD at some point of their ICU stay.
Figure  2 depicts the value of Ptr,stim on initiation of 
MV and during ICU. In patients with a “Persistent Dys-
function” pattern, Ptr,stim was 5.8 (5.1–7.6)  cmH2O on 
initiation of MV and did not change during the ICU 
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stay [4.6 (3.8–5.7)  cmH2O after 7.5 (5.0–13.0) days, 
p = 0.313]. In patients with an “Improving Dysfunction” 
pattern, Ptr,Stim increased from 7.1 (4.5–8.4)  cmH2O 
on initiation of MV to 12.8 (12.4–14.5)  cmH2O after 
7.0 (6.0–13.0) days (p =  0.004). Ptr,stim on ICU admis-
sion was not different between patients with a “Persis-
tent Dysfunction” pattern and those with an “Improving 
Dysfunction” pattern (p  =  0.395). In patients with an 
“Acquired Dysfunction” pattern, Ptr,stim deceased from 
13.2 (11.7–14.6) cmH2O on initiation of MV to 7.9 (5.1–
9.3) cmH2O after 7.0 (4.0–11.0) days (p = 0.001). Finally, 
in patients with a “No Dysfunction” pattern, Ptr,stim was 
20.0 (16.3–25.7) cmH2O on initiation of MV and did 
not decrease [20.9 (15.8–25.1) cmH2O after 4.0 (3.0–
7.0) days, p = 0.839]. Ptr,stim on admission was signifi-
cantly lower in patients with an “Acquired Dysfunction” 
pattern than in those with a “No Dysfunction” pattern 
(p = 0.005).
Univariate analysis showed that, among patients with 
diaphragm dysfunction on initiation of MV, patients 
with an “improving dysfunction” pattern tended to have 
a lower body mass index (Table  1). In patients without 
diaphragm dysfunction on ICU admission, no risk factor 
was associated with subsequent acquisition of diaphragm 
dysfunction (Table 2).
When Ptr,stim was assessed as a continuous vari-
able, factors associated with a change in Ptr,stim were: 
age [linear coefficient regression (Coeff.) −0.097, stand-
ard error (SD) 0.047, p = 0.046], PaO2/FiO2 ratio (Coeff. 
0.014, SD  0.006, p =  0.0211) and the proportion of the 
time under MV with sedation (per 10 %, Coeff. −5.359, 
SD 2.451, p = 0.035).
Clinical outcomes
Table 3 displays the major clinical outcomes. ICU mortal-
ity was higher in patients with a “Persistent Dysfunction” 
pattern than in those with a “No Dysfunction” pattern 
(p  =  0.03). Moreover, mortality was higher in patients 
with diaphragm dysfunction either on initiation of MV or 
during the subsequent ICU stay than in those in whom 
diaphragm dysfunction was never observed (35 vs. 0  %, 
p = 0.04).
Duration of mechanical ventilation was higher in 
patients with a “Persistent Dysfunction” pattern than in 
those with a “No Dysfunction” pattern (p = 0.04). Among 
patients with diaphragm dysfunction on initiation of 
MV, the duration of mechanical ventilation tended to be 
higher in those with a “Persistent Dysfunction” pattern 
than in those with an “Improving Dysfunction” pattern 
(p = 0.072). Among patients without diaphragm dysfunc-
tion at the time of intubation, the duration of mechani-
cal ventilation tended to be higher in those with an 
“Acquired Dysfunction” pattern than in those with a “No 
Dysfunction” pattern (p = 0.064).
Discussion
This study shows that mechanically ventilated ICU 
patients can exhibit various patterns of diaphragm func-
tion, defined as the capacity of the diaphragm to produce 
a negative intrathoracic pressure in response to phrenic 
nerve stimulation. Overall, 79  % of patients developed 
diaphragm dysfunction at some point of their ICU stay.
Two major patterns of diaphragm dysfunction have 
been described in humans. The first of these two pat-
terns is diaphragm dysfunction on initiation of MV. Like 
Mechanical ventilation ≥5 days




































Fig. 1 Study flow chart. ICU intensive care unit
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all striated muscles, the diaphragm can be involved in the 
shock-related organ failure observed in many patients on 
admission to the ICU [3], in which sepsis plays a major 
role [12]. This phenomenon has been clearly established 
for the heart [13]. It also involves limb muscles, as sug-
gested by electromyographic and histopathological stud-
ies conducted soon after ICU admission. These studies 
have shown that more than 50 % of patients with severe 
sepsis exhibit signs of neuromuscular damage [14]. Dia-
phragm dysfunction on admission was observed in 64 % 
of patients in our first cohort [3] and in 53 % of patients 
in the present study, which is ancillary to the first cohort. 
The difference between these two rates can be explained 
by the fact that only patients mechanically ventilated 
for at least 5  days were included in the present study. 
Because diaphragm dysfunction on admission is associ-
ated with higher mortality [3], some patients died before 
day 5 and were therefore not included in the analysis. 
The second pattern of diaphragm dysfunction described 
in humans is ICU-acquired diaphragm dysfunction in 
mechanically ventilated patients [4, 5, 15], which is partly 
a consequence of mechanical ventilation, known as ven-
tilator-induced diaphragm dysfunction (VIDD). It results 
from striated muscle disuse atrophy [15] and injury 
[16]. In addition, diaphragm strength is also sensitive to 
ICU-acquired neuromuscular disorders [6] and hyperca-
tabolism and corticosteroid use [17] that are frequently 
observed in the ICU.
Fig. 2 Individual endotracheal tube pressure induced by bilateral phrenic nerve stimulation (Ptr,stim) on admission and during the subsequent 
intensive care unit stay in the four groups defined by the four patterns
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Table 1 Characteristics of the study population on intensive care unit admission
Continuous variables are expressed as median (interquartile range), and categorical data are expressed as number (%)
ICU intensive care unit, BMI body mass index, SAPS simplified acute physiology score, MV mechanical ventilation
Diaphragm dysfunction on admission
n = 23











Age (years) 75 (54–78) 58 (48–70) 62 (54–72) 59 (53–79) 0.508
Gender (M) 8 (57) 3 (33) 7 (63) 6 (66) 0.515
BMI (kg/m2) 27.1 (23.8–29.1) 22.4 (19.4–24.7) 25.1 (23.8–30.2) 24.4 (23.8–26.1) 0.095
SAPS II 55 (48–70) 61 (32–71) 45 (44–57) 49 (47–53) 0.510
Type of admission: medical [n (%)] 10 (71) 8 (89) 8 (73) 7 (78) 0.859
Indication for MV 0.069
 Shock [n (%)] 1 (7) 1 (13) 0 0
 Coma [n (%)] 3 (21) 0 5 (45) 6 (67)
 ARF [n (%)] 10 (71) 8 (88) 6 (55) 3 (38)
Table 2 Characteristics of the study population at first diaphragm assessment and during intensive care unit stay
Continuous variables are expressed as median (interquartile range), and categorical data are expressed as number (%)
ICU intensive care unit, SOFA sequential organ failure assessment, MV mechanical ventilation
Diaphragm dysfunction on admission
n = 23











At first diaphragm assessment
SOFA 9 (8–10) 9 (5–11) 8 (7–8) 6 (4–10) 0.573
Sepsis [n (%)] 11 (79) 7 (78) 6 (55) 3 (33) 0.121
PaO2/FiO2 (mmHg) 211 (141–302) 208 (143–281) 202 (120–295) 314 (120–460) 0.593
PaCO2 (mmHg) 38 (33–45) 36 (31–37) 33 (31–38) 35 (31–39) 0.635
pH 7.41 (7.31–7.46) 7.41 (7.33–7.47) 7.39 (7.33–7.49) 7.45 (7.31–7.49) 0.854
Blood lactate (mmol/L) 2.5 (1.3–3.2) 1.5 (1.2–2.9) 2.3 (1.7–3.4) 1.9 (1.2–3.00) 0.626
During ICU stay
Sedation (% of ICU stay) 54 (30–75) 67 (25–71) 50 (33–73) 33 (13–43) 0.302
Amines (% of ICU stay) 100 (0–100) 100 (0–100) 6 (0–100) 0 (0–71) 0.189
Controlled MV (% of ICU stay) 64 (43–80) 71 (25–83) 50 (33–75) 33 (25–43) 0.610
Table 3 Main clinical outcomes
Continuous variables are expressed as median (interquartile range), and categorical data are expressed as number (%)
ICU intensive care unit, MV mechanical ventilation, LOS length of stay
Diaphragm dysfunction on admission
n = 23











Duration of MV (days) 18 (15–21) 10 (7–20) 11 (6–18) 5 (4–7) 0.012
Tracheotomy, [n (%)] 3 (23) 2 (25) 1 (9) 1 (13) 0.799
ICU mortality [n (%)] 7 (54) 1 (13) 4 (37) 0 0.037
Hospital mortality [n (%)] 8 (62) 1 (13) 4 (37) 2 (25) 0.139
ICU LOS (days) 21 (18–27) 13 (10–24) 15 (9–30) 8 (7–14) 0.212
Hospital LOS (days) 21 (18–44) 27 (12–47) 17 (9–72) 18 (13–24) 0.832
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To the best of our knowledge, this is the first study 
to report the relative incidence of these two phenom-
ena: 53  % of patients presented diaphragm dysfunction 
on initiation of MV and 26  % presented no diaphragm 
dysfunction on admission, but subsequently developed 
diaphragm dysfunction. We also show that these two 
phenomena may be interrelated. For instance, 33  % of 
the patients who presented diaphragm dysfunction on 
ICU initiation of MV never recovered, as VIDD may 
have contributed to prevent any form of recovery in these 
patients. It is noteworthy that mortality tended to be 
higher in the subgroup of patients in whom diaphragm 
function did not recover, suggesting that the combina-
tion of these two phenomena may worsen the prognosis. 
Twenty-one per cent of patients had a diaphragm dys-
function on initiation of MV and subsequently recov-
ered, suggesting that even severe diaphragm dysfunction 
on admission can be reversed. This is consistent with 
echocardiographic and physiological findings in patients 
with sepsis-associated myocardial dysfunction, which 
show reversibility over a period of 7–10 days [18]. Finally, 
21 % of patients never exhibited diaphragm dysfunction, 
either on initiation of MV or during ICU stay. Although 
this study was not designed to assess causality, it is note-
worthy that the proportion of the time under mechanical 
ventilation spent on a controlled mode of ventilation as 
opposed to a partial mode of ventilatory assistance was 
associated with the decrease of Ptr,stim. This finding sup-
ports the contribution of controlled mechanical ventila-
tion and subsequent diaphragm rest to the pathogenesis 
of ICU-acquired diaphragm dysfunction.
Our data are original since this is to the best of our 
knowledge the first study to provide longitudinal data 
on diaphragm function on initiation of MV and during 
the subsequent ICU stay. Among the few studies that 
describe diaphragm function in the ICU with Ptr,stim, 
none has longitudinally described patterns of diaphragm 
function in a cohort of similar size. The two the largest 
series studied patients either upon initiation of mechani-
cal ventilation or at various time points, but the time 
trend in diaphragm function was not described [3, 19]. 
Two studies have reported variation of diaphragm func-
tion during ICU stay, but on much smaller samples [4, 5]. 
Finally, in a recent report, diaphragm function was stud-
ied in 40 patients with ICU acquired diaphragm weak-
ness, but only at the time of extubation [20].
One of the strengths of this study is that diaphragm 
strength was tested by bilateral phrenic nerve stimula-
tion, a gold standard method that provides a specific 
measurement of the capacity of the diaphragm to gener-
ate an inspiratory pressure [21]. Many reports of ultra-
sound or CT-scan evaluation of diaphragm morphology 
in ICU patients have been published [22–24]. However, 
these techniques do not constitute the gold standard 
for assessment of diaphragm function and few data are 
available to establish a correlation between ultrasound 
measurements and Ptr,stim [20], which remains the gold 
standard for assessment of diaphragm function in ICU 
patients. Another strength is that the study was con-
ducted in two centres and the study population is repre-
sentative of standard ICU recruitment.
Our study presents several limitations. Diaphragm 
function was assessed by measuring tracheal pressure 
(Ptr,stim) without the use of oesophageal and gastric 
probes to measure transdiaphragmatic pressure, which 
would have been more precise, but also more invasive, 
and much less practical in a large cohort. We cannot rule 
out that other factors aside from intrinsic diaphragm dys-
function may have contributed to changes in Ptr,stim. 
This would be the case of a decrease in positive end-
expiratory pressure and subsequent improvement in dia-
phragm length–tension relations. However, patients with 
severe chronic obstructive pulmonary disease were not 
included. There is a clear lack of power due to the lim-
ited sample size. We were therefore unable to identify any 
independent risk factors for improvement or worsening 
of diaphragm function. Finally, our choice of a diaphragm 
dysfunction cut-off of 11  cmH2O may be questionable. 
However, this choice was based on published reports 
[10, 11], was validated in a population of patients briefly 
anaesthetized and mechanically ventilated for elective 
surgical procedures and was subsequently used in a pre-
vious report [3].
Conclusion
 A large majority of patients mechanically ventilated 
for at least 5  days exhibit diaphragm dysfunction at 
some point during their ICU stay. Diaphragm dysfunc-
tion presents many different patterns in these patients, 
comprising diaphragm dysfunction on admission and 
ICU-acquired diaphragm dysfunction. Larger studies 
are needed to determine the risk factors for diaphragm 
function changes and the clinical consequences of these 
changes in mechanically ventilated ICU patients.
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